Takeda Launches Largest Pharmaceutical Company-Sponsored Global Observational...
CAMBRIDGE, Mass. & OSAKA, Japan Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that its global non-interventional, observational multiple myeloma study is now enrolling...
View ArticleCook Medical Names Jean-Marc Creissel Vice President of Operations in Greater...
BLOOMINGTON, Ind. Cook Medical is pleased to announce that Jean-Marc Creissel has been named vice president of operations for the greater China region. In his new role, Creissel will work with the...
View ArticleAncillare’s Peter Knapp to Kick off “Innovating the Supply Chain” at the...
HORSHAM, Pa. Ancillare, LP, the leader in end-to-end global clinical trial ancillary supply chain management services for pharmaceutical, biotechnology, contract research and medical research...
View ArticleIMS Health和昆泰公布合并公司关键高管名单
康涅狄格州丹伯里和北卡罗莱纳州三角研究园 (美国商业资讯)–IMS Health Holdings, Inc. (NYSE:IMS) 和昆泰跨国控股公司(Quintiles Transnational Holdings Inc., NYSE:Q)今日公布合并完成后的昆泰IMS未来公司领导团队关键高管名单。 董事长兼首席执行官Ari...
View ArticleIMSヘルスとクインタイルズが合併会社の主要な役員を発表
米コネティカット州ダンバリー & 米ノースカロライナ州リサーチ・トライアングル・パーク (ビジネスワイヤ) — IMSヘルス・ホールディングス・インク(NYSE:IMS)とクインタイルズ・トランスナショナル・ホールディングス・インク(NYSE:Q)は本日、合併完了を前提とし、今後のクインタイルズIMSコーポレート・リーダーシップチームの主要な上級経営陣を発表しました。...
View ArticleThe 15th Endocrine Regulations Prize of the Fondation IPSEN is Awarded to...
PARIS The Fondation IPSEN Endocrine Regulations Prize will be awarded this year at the ICE-CSE (International Congress of Endocrinology – Chinese Society of Endocrinology), in Beijing on September...
View Articleマシモ、ジカウイルスの影響を受けている地域を対象とする総ヘモグロビン(SpHb®)モニタリングの特別な世界的プログラムを発表
米カリフォルニア州アーバイン (ビジネスワイヤ) — マシモ(NASDAQ:...
View ArticleDr. Reddy’s Announces Purple Health, a Unique Patient-Centric Platform That...
HYDERABAD, India Dr. Reddy’s Laboratories Ltd (BSE: 500124, NSE: DRREDDY, NYSE: RDY) today announced the launch of Purple Health, a unique platform designed to inspire patient-centric innovation and...
View ArticleThe IMS Institute for Healthcare Informatics Launches Asia Branch
SINGAPORE The IMS Institute for Healthcare Informatics today announced the launch of a new branch focused on supporting improved health outcomes across Asia. Based in Singapore, the team will forge...
View ArticleNeuroMetrix Announces Issuance of Patent for DPNCheck Core Technology in China
WALTHAM, Mass. NeuroMetrix, Inc. (Nasdaq: NURO) announced today that the State Intellectual Property Office of the People’s Republic of China has issued Chinese Patent No. ZL20118055305.7 for the...
View ArticleTakeda to develop Zika Vaccine with up to $312 million in funding from US...
OSAKA, Japan Takeda Pharmaceutical Company Limited [TSE: 4502], (“Takeda”) today announced that BARDA, the Biomedical Advanced Research and Development Authority, has selected Takeda’s Vaccine...
View ArticleReSound®重返在柏林举办的全球最大的消费类电子产品展览会,展示最先进的听力解决方案
柏林 (美国商业资讯)–本周,ReSound将重返全球最大的国际消费类电子产品展览会IFA,重点展示其屡获殊荣的智能助听器(Smart Hearing),同时协助主持讨论,探讨如何为听力医疗保健专业人员提供支持,其目的旨在让听力损失患者在试戴过程和日常生活中获得最高的满意度。全球有5亿多人饱受听力损失之苦,其中包括1,300万至1,500万德国人。...
View Articleマシモが世界麻酔学会連合(WFSA)と期間4年のパートナーシップを発表
米カリフォルニア州アーバイン & 香港 (ビジネスワイヤ) — マシモ(NASDAQ: MASI)は日曜日、香港で開催中の世界麻酔学会(WCA)にて、世界麻酔学会連合(WFSA)の初のグローバルインパクトパートナーになったと発表しました。期間4年のパートナーシップ「安全な麻酔―ASAP」(麻酔安全行動計画、Anesthesia Safety Action...
View ArticleDr. Reddy’s Laboratories Announces the Launch of Bupropion HCl...
HYDERABAD, India & PRINCETON, N.J. Dr. Reddy’s Laboratories Ltd (BSE: 500124, NSE: DRREDDY, NYSE: RDY) announced today that it has launched Bupropion HCl extended-release tablets, USP (SR) in...
View ArticleAlvogen Launches First Generic Equivalent of CopaxoneTM in Europe
PINE BROOK, N.J. Alvogen today announced the launch of RemurelTM (glatiramer acetate), the first generic equivalent of CopaxoneTM in Central and Eastern Europe. The product will be marketed as a...
View ArticleWOUNDCHEK™ Protease Status receives market clearance in Australia
FALL RIVER, Mass. WOUNDCHEK™ Laboratories announced today that WOUNDCHEK™ Protease Status, the world’s first point of care wound diagnostic for chronic wounds, has received market clearance from the...
View ArticleSalutarisMD to Introduce its New Generation Medical Device for wet AMD...
COPENHAGEN, Denmark Today, Salutaris Medical Devices, Inc. (SalutarisMD®) announced that during its upcoming presentation at the Ophthalmology Futures European Forum on September 8, the Company will...
View ArticleAcelity Announces Proposed Private Offering of $1,750 Million of Second Lien...
SAN ANTONIO Acelity L.P. Inc. (“Acelity”), a global advanced wound care and regenerative medicine company, announced today that its wholly-owned subsidiaries, Kinetic Concepts, Inc. (“KCI”) and KCI...
View ArticleAcelity Announces Exchange Offer and Consent Solicitation with Respect to...
SAN ANTONIO Acelity L.P. Inc. (“Acelity”), a global advanced wound care and regenerative medicine company, announced today that its wholly-owned subsidiaries, Kinetic Concepts, Inc. (“KCI”) and KCI...
View Article